Printer Friendly
The Free Library
5,667,357 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Nymox Pharmaceutical Corporation - Announcement.


MONTREAL--(BUSINESS WIRE)--June 27, 1997--(ME NMX NMX Normas Mexicanas (non-mandatory Mexican standard)
NMX Network Modular Extension
.) Nymox Pharmaceutical Corporation of Montreal Of Montreal is an American indie pop band formed in Athens, Georgia, fronted by Kevin Barnes. It was among the second wave of groups to emerge from The Elephant 6 Recording Company. , Canada, together with Nymox Corporation of Rockville, Maryland, USA, is pleased to announce the appointment of Michael H. Barnes to the Nymox Board of Directors. Mr. Barnes is Managing Editor of The Bank Credit Analyst Research Group, a highly-respected and widely- read investment publication. Prior to joining The Bank Credit Analyst Research Group in 1987, Mr. Barnes was the Chief Economist at Wood Mackenzie, a leading Edinburgh brokerage firm (1977-1987) and an economist at British Petroleum in London (1973-1977). He has published extensively and speaks frequently to major investment audiences throughout the world.

Nymox is a leading biomedical bi·o·med·i·cal
adj.
1. Of or relating to biomedicine.

2. Of, relating to, or involving biological, medical, and physical sciences.
 company which specializes in the research and development of diagnostics and pharmaceuticals with emphasis on the aging population and Alzheimer's disease Alzheimer's disease (ăls`hī'mərz, ôls–), degenerative disease of nerve cells in the cerebral cortex that leads to atrophy of the brain and senile dementia. . Nymox has developed and is beginning to market its unique patented AD7C test for use in Alzheimer's disease. AD7C is a major breakthrough technology and is the only test with an accuracy similar to that of a postmortem postmortem /post·mor·tem/ (post-mort´im) performed or occurring after death.

post·mor·tem
adj.
Relating to or occurring during the period after death.

n.
See autopsy.
 in the diagnosis of Alzheimer's disease.

Nymox also announces it has incurred a loss of CAN$3,699,064 for the year ended December 31, 1996 ($0.21 per share). This loss is directly attributable to research and development activities and to the pre-commercialization expenses of its AD7C test for Alzheimer's Disease.

Nymox is listed on the Montreal Exchange Montreal Exchange

A Canadian derivatives exchange that facilitates the trading of stock options, interest rate futures and options, as well as index options and futures. Located in Montreal, Quebec, it is the country's main financial derivative market, while the Winnipeg
 under the symbol NMX.

NO REGULATORY AUTHORITY HAS APPROVED NOR DISAPPROVED THE CONTENT OF THIS RELEASE.

CONTACT: Nymox Pharmaceutical Corporation, 800/93NYMOX

info@nymox.com

http://www.nymox.com
COPYRIGHT 1997 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1997, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jun 27, 1997
Words:258
Previous Article:American Ref-Fuel Co. of Niagara Rtgs Reinstated by S&P.
Next Article:Colony Reports Second Quarter Results for the Six Months Ended April 30, 1997.
Topics:



Related Articles
Nymox Reports Favorable Results in 500 Patient Study of Test to Rule out Alzheimer's Disease.
Nymox Launches U.S. Subsidiary.
Nymox Announces Drug Candidate NX D2858 for Alzheimer's Disease.
Nymox announces new agreement for Alzheimer's Disease Therapeutics With Massachusetts General Hospital.
Nymox Pharmaceutical - at the request of the Montreal Exchange.
Nymox Researchers Find Revolutionary New Time Bombs in the Human Brain Called "Spherons" Which May be a Major Cause of Alzheimer's Disease.
Nymox Finalizes Acquisition of Majority Interest in Serex, Inc.
Nymox Announces Serex Development of New Saliva Cholesterol Test.
Nymox-Serex's Nicotine Test Shown to be Useful in Pediatric Second Hand Smoke Studies.
WallStreet Research Updates Coverage of Nymox Pharmaceutical Corporation Shares with Speculative Buy Recommendation at www.WallStreetResearch.org.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles